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Abstract
Background: Older persons may suffer more from travel-related health problems because of ageing and underlying
chronic disorders. Knowledge on who is more likely to have these health problems helps to tailor travel health
advice more specifically. This study aimed to determine predictors of travel-related morbidity in older travellers by
assessing their pre-travel characteristics and performance using physical and cognitive functioning tests.
Methods: Multicentre prospective cohort study among older travellers (≥60 years) who consulted one of the par-
ticipating Dutch travel clinics. Handgrip strength and cognitive performance were measured pre-travel. Participants
completed questionnaires before departure and 1 and 4 weeks after return. A diary recorded health complaints
during travel until 2-week post-travel.
Results: In total, 477 travellers completed the study (follow-up rate of 97%). Participants’ median age was 66 years.
The most visited regions were South-East Asia (34%) and South Asia (14%). Median travel duration was 19 days.
Polypharmacy (≥5 medications per day) was not uncommon (16%). The median Charlson Comorbidity Index
(CCI) score was 0. Self-reported travel-related infectious diseases concerned primarily respiratory tract infections
(21%) and gastroenteritis (10%) whereas non-infectious complaints were injuries (13%), peripheral edema (12%)
and dehydration (3%). Medical assistance was sought by 18%, mostly post-travel from their general practitioner
(87%). Self-reported physical and mental health-related quality of life significantly improved during and after travel.
Predictors for an increased risk of travel-related morbidity were higher CCI score, more travel experience, longer
travel duration, higher number of daily medications, visiting northern Africa or South-East and East Asia, and phone
and social media use.
Conclusion: Older Dutch travellers are generally fit, well-prepared and suffer not only from common infectious
health problems, but also from injuries. Travel improved their self-perceived health. The predictors could be used
to identify the more at-risk older traveller and to decrease travel-related morbidity by optimizing pre-travel advice.
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Introduction
Over the past decades, increase in life expectancy and vitality
has led to a growing older population traveling internationally.1
In previous studies 15–30% of all international travellers were
older adults.2–4 Between 1995 and 2017, the percentage of Dutch
travellers to tropical destinations has almost doubled from 8%
to 16%.5 It is conceivable that this also holds true for older
travellers.
The travel-related morbidity of older travellers is expected
to differ from that of younger travellers due to physiological,
medical and behavioural differences.6–9 Due to their altered
homeostasis older persons may suffer more from exposure
to extreme climate and environmental conditions, potentially
resulting in increased susceptibility to dehydration and hyper-
or hypothermia.10–13 In addition, older persons are more
susceptible to infections due to impaired immune responses,
waning immunity and limited effectiveness of pre-travel
vaccinations.4 ,14–17 Moreover, polypharmacy and underlying
chronic disorders, including cardiovascular disease, diabetes
mellitus (DM) and chronic respiratory diseases are more
prevalent among older persons.18–23 This poses a risk of decreased
physical functioning, drug-related side effects and drug–drug
interactions or exacerbations of pre-existing illnesses during
travel.10 ,21 ,24–26 Yet, older travellers choose different, possibly
lower-risk destinations and travel modes and show less risky
behaviour, which may diminish their travel-related health
risks.7 ,27
A case-control study by Gautret et al. revealed that the
observed proportion of illnesses, such as lower respiratory tract
infections (RTIs), trauma and injuries, urinary tract infections
and heart disease, was higher in the older travellers visiting
a travel clinic post-travel compared with younger travellers.6
Illnesses such as acute diarrhoea, upper RTIs, mild malaria and
dengue, were less frequently observed. However, the generaliz-
ability of these findings may be limited due to confounding by
indication as only ill older travellers presenting themselves at the
clinic post-travel were included.
Our aim was to identify predictors related to the occurrence
of morbidity in older travellers during their tropical travel and
shortly thereafter. To that end we evaluated their pre-travel
performance using physical and cognitive functioning tests and
determined the incidence, duration and inconvenience of travel-
related morbidity in a prospective cohort.
Methods
Design and participants
We conducted a multicentre prospective observational cohort
study among older adults traveling to tropical destinations
(ELDEST study, morbidity in ELDErly travellers during a Short-
Term stay abroad). Travellers were informed and recruited
during their regular visit at four Dutch travel clinics between
July 2016 and November 2017 [LUMC in Leiden (coordinating
centre), Harbor Hospital Rotterdam and Municipal Health
Services (MHSs) Rotterdam-Rijnmond and Haaglanden].
Inclusion criteria were: age ≥ 60 years, a scheduled travel to a
tropical destination and a travel duration of ≤35 days. Exclusion
criteria were inability to complete diary and questionnaires
because of foreign language, or cognitive disability (i.e. suffering
from memory disorders) or visiting the clinic less than 2 weeks
prior to departure.
The study consisted of two parts. Part A collected pre-travel
basic demographic information, and travellers completed phys-
ical and cognitive functioning tests. For logistical reasons, the
cognitive test could not be performed at the MHSs sites. In
part B, travellers completed pre- and post-travel questionnaires.
In addition, a diary on travel-related health complaints was
kept starting 1-week pre-travel, during travel until 2-week post-
travel. Depending on their willingness to participate, travellers
were included solely in part A or in both parts. This study
was approved by the Medical Ethical Committee of the LUMC
(registry number P16.056). All participants signed an informed
consent. We followed the strengthening the reporting of observa-
tional studies in epidemiology (STROBE) reporting guideline.
Functional tests (part A)
Hand grip strength is correlated with physical functioning and
several important health outcomes.28 Grip strength was defined
as the maximum strength from three attempts, measured with the
Jamar Hydraulic hand dynamometer.29 ,30 The six item cognitive
impairment test (6CIT) was conducted to assess the level of
cognitive deficits.31 ,32 This test can be completed within 3–
4 min and consists of six weighted items including one memory,
two attention and three orientation questions. The 6CIT is not
influenced by education level.32 A higher score is associated with
more cognitive impairment (Supplementary Appendix 1).
Questionnaires (part B)
Questionnaires were pre-tested among older adults for clarity
and comprehensibility before start of the study. Travellers com-
pleted questionnaires at different time points: 1-week pre-travel,
1-week post-travel and 4-week post-travel. If travellers reported
health complaints in the third questionnaire, an additional ques-
tionnaire was filled out 8-week post-travel.
Questionnaire 1 captured demographic data, medical history,
medication and travel characteristics. In addition, three standard-
ized tests were included to identify potential risk profiles based
on health status, independence and (co)morbidity. Self-reported
health status was assessed by the Short Form 36 health survey
(SF-36) measuring eight health domains: physical functioning,
social functioning, role limitations due to physical or emotional
problems, mental health, vitality, bodily pain and general health
perception.33 A higher SF-36 score is associated with a bet-
ter health status (range 0–100). The level of independence of
performing daily activities (e.g. dressing) was measured using
the Katz activities of daily living (Katz-ADL).34 ,35 A higher
Katz-ADL score is associated with more dependence (range 0–
26). The comorbidity burden was assessed with the Charlson
Comorbidity Index (CCI), a tool to measure comorbidity and
to estimate 10-year survival (Supplementary Appendix 2).36 ,37
Questionnaire 2 concerned travel preparation, risk behaviour,
health complaints and treatment. Post-travel health complaints
and (possible) medical treatment were evaluated in questionnaire
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Diary (part B)
Health complaints and experienced inconvenience were reported
daily in a paper diary, starting 1-week pre-travel until 2-week
post-travel. Every traveller received a digital thermometer for
measuring body temperature in case of illness.
Definitions
Polypharmacy was defined as the use of five or more medica-
tions per day (not including malaria prophylaxis).38 Diarrhoea
was defined as the passage of three or more unformed stools
during a 24-h period (WHO definition).39 Fever was defined
as body temperature ≥ 38◦C. Travel destinations were catego-
rized according to geographical regions of the United Nations
Statistics Division.40 Travel-related morbidity was categorized by
evaluating the presence, duration, inconvenience and treatment
of predefined symptom clusters using the diaries (Supplementary
Appendix 3). Symptom clusters were defined on the presence
of health complaints, matching the Dutch General Practitioners
guidelines as closely as possible.41
Sample size
We estimated that ∼20% of older travellers would experience
some kind of health problem during their foreign stay, but data
for Dutch older travellers are lacking. Therefore, a formal power
calculation was not performed. As many travellers as feasible
were included within the timeframe of the project with the
intention to collect complete data of at least 100 travellers aged
between 70 and 79 years old, which would result in at least 20
travellers with health problems in this age group. Based on the
age distribution of the participating centres in the past years and
an attrition rate of 25%, a total of 625 inclusions were estimated
to be required for this study to achieve this goal.
Statistical analysis
Statistical analyses were conducted using SPSS software, version
23 (IBM Corp). Firstly, descriptive analyses and univariable anal-
ysis were used for demographical, (physical) health status and
travel characteristics of travellers participating in A and B. Trav-
ellers aged 60–69 years were compared with travellers 70 years or
older in our cohort regarding the pre-travel health characteristics.
Secondly, incidence, duration, experienced inconvenience and
treatment of travel-related morbidity were determined. SF-36
scores were compared using Wilcoxon signed rank test. Thirdly,
logistic regression analyses were performed to identify predictors
for travel-related morbidity using univariable and multivariable
analysis. Without preselection from the univariable analysis,
variables were entered in a multivariable logistic regression using
backward elimination until the Akaike information criterion
(P < 0.157) was minimized. In accordance with the guidelines for
establishing prediction models, we selected the Akaike informa-
tion criterion above the classic method of statistical significance
with a P-value < 0.05 because otherwise important variables
could be indicated as ‘non predictive’ due to the relatively small
sample size.42 The Nagelkerke R,2 Hosmer and Lemeshow test,
Brier score and c-index of the model were assessed to determine
the performance of the model. The 6CIT total score could not be
included in the model, as it was unavailable for travellers which
were included at the MHSs. Associations were reported as odds
ratios, 95% confidence intervals (CI) and P-values.
Results
Study population and travel characteristics
In total, 1003 travellers were invited, of whom 649 were included
in part A (35% non-participation). Of these, 477 travellers
(73%) were available for case analysis (Part A and B, follow-
up rate questionnaires 97%) (Figure 1). Demographic and travel
characteristics are shown in Supplementary Table S1. The median
age was 66 years [interquartile range (IQR) 63–70]; 132 (28%)
were aged 70 years and over.
Travellers were generally fit with an overall median 6CIT
total score of 0 (IQR 0–2) and a median grip strength of 34 kg
(IQR 28–45) (Table 1). The most visited regions were South-
Eastern Asia (34%), and Southern Asia (14%) (Supplementary
Figure S1). The median time spent abroad was 19 days (IQR 14–
23). Almost all travellers owned a mobile phone (98%) and many
used social media (60%) (Supplementary Table S1).
Pre-travel health characteristics
Polypharmacy was not uncommon among participants. One
third of all travellers did not use any medication at all; 16%
used five or more daily medications. In travellers aged 70 years
and over polypharmacy occurred more frequently (P = 0.003).
Katz-ADL revealed that 97% of travellers could be classified as
independent. The median CCI was 0 (IQR 0–1), corresponding
with an estimated 10-year survival of 92%.36 Pre-travel perfor-
mance scores, particularly grip strength, 6CIT and CCI, were
significantly worse in travellers aged ≥ 70 years. Overall, the
three most observed pre-existing conditions were cardiovascular
diseases (44%, mainly hypertension), malignancies (16%) and
skin diseases (10%) (Table 1).
Travel preparation
The majority of travellers booked their travel online (60%).
They frequently consulted sources for advice, such as the gen-
eral practitioner (GP, 91%) and the internet (18%). Nearly all
travellers had a travel insurance (97%). Travellers often carried
self-medication for diarrhoea such as loperamide (73%), and
oral rehydration solution (ORS, 60%) (Supplementary Table S2).
Also hand-hygiene products, such as hand sanitizers (58%), were
brought along of which 75% (207/275) used these regularly
(Supplementary Table S3).
Risk behaviour
Travellers showed various kinds of risk behaviour such as con-
suming unpeeled fruit (76%), raw food products (27%, i.e. crus-
taceans or shellfish) or eating at street vendors (19%). Regular
hand washing before a meal was practiced by 84% of travellers.
About 20% reported contact with animals that mostly involved
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Table 1. Pre-travel health characteristics of 477 older travellers to the tropics
Available Cases All agesa
N = 477
Available Cases 60–69 years
N = 345




BMI, kg/m2, median (IQR) 25.4 (23–28) 25.4 (23–28) 24.9 (23–28) P = 0.514i
Sensory function
Wearing glasses or contact lensesb 366 (77) 261 (77) 105 (80) P = 0.395
Wearing hearing aidb 53 (11) 25 (7) 28 (21) P < 0.001
Influenza vaccination received in the past yearb 265 (56) 167 (48) 98 (74) P < 0.001
Katz-ADL score, median (IQR)bc 0 (0–0) 0 (0–0) 0 (0–0) P = 0.138
0 461 (97) 336 (98) 125 (95)
1 15 (3) 8 (2) 7 (5)
Grip strength, kg, median (IQR)d 34 (28–45) 35 (28–46) 32 (25–42) P < 0.001i
6CIT total score, median (IQR)e N = 303
0 (0–2)





CCI score, median (IQR) 0 (0–1) 0 (0–1) 1 (0–2) P < 0.001
0 287 (60) 226 (66) 61 (46)
1 79 (17) 58 (17) 21 (16)
2 66 (14) 37 (11) 29 (22)
3 23 (5) 13 (4) 10 (8)
4 8 (2) 3 (1) 5 (4)
≥5 14 (3) 8 (2) 6 (4)
Number of medication per day, median (IQR) 1 (0–3) 1 (0–3) 1 (0–4) P = 0.011
None 159 (33) 125 (36) 34 (26)
1–5 271 (57) 195 (57) 76 (58)
6–10 42 (9) 23 (7) 19 (14)
11–13 5 (1) 2 (1) 3 (2)
Polypharmacy (≥5 medications per day) 77 (16) 45 (13) 32 (24) P = 0.003
Medical history
Any cardiovascular diseasef 212 (44) 131 (38) 81 (61) –
Hypertension 134 88 (26) 46 (36) P = 0.039
Cardiac arrhythmia 32 16 (5) 16 (12) P = 0.003
Myocardial infarct 13 7 6 P = 0.204
Angina pectoris 5 3 2 P = 0.620
Cardiac failure 3 2 1 –
Malignancy 76 (16) 41 (12) 35 (27) P < 0.001
With metastases 8 5 3
Skin disease 49 (10) 34 15 P = 0.627
Urinary tract infection(s) < 12-month pre-travelb 36 (8) 26 10 P = 0.995
Pulmonary disease 39 (8) 29 10 P = 0.767
Asthma 22 19 3
COPD 14 9 5
Auto-immune disorderb 32 (7) 18 14 P = 0.036
Diabetes mellitus 30 (6) 19 (6) 11 (8) P = 0.259
With complications 7 5 2
Gastric disease 22 (5) 17 5 P = 0.808
Intestinal disease 16 (3) 10 6 P = 0.397
Ulcerative colitis/Crohn’s disease 3 2 1
Renal disease 15 (3) 8 7 P = 0.138
Kidney transplant 5 3 2
Liver disease 6 (1) 4 2 P = 0.671
HIV 1 (0) 0 1 –
Dementiag 1 (0) 0 1 –
Data represent absolute numbers (N) and percentages (%), unless otherwise specified. Abbreviations: BMI, body mass index; IQR, interquartile range; Katz-ADL, Katz activities of daily
living; 6CIT, Six Item Cognitive Impairment Test;; CCI, Charlson comorbidity index; COPD, Chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.
aAvailable cases are eligible travellers that participated in part A and B.
bPercentages were calculated over the total number of travellers that answered the concerning question. Some travellers did not fill in the questions concerning these items, resulting in a
maximum of three missing values.
cKatz-ADL: range 0–26.
dGrip strength: range 0–90 kg. For procedure, see Supplementary Appendix 1.
e6CIT: range 0–28. For procedure, see Supplementary Appendix 1. Measurements were unavailable for travellers included at the Municipal Health Services.
fThis group variable represents the number of cardiovascular events including hypertension (n = 134), cardiac arrhythmia (n = 32), myocardial infarct (n = 13), angina pectoris (n = 5),
cardiac failure (n = 3), transient ischemic attack (n = 8), cerebral infarction (n = 3) peripheral vascular disease (n = 14). Some travellers had multiple cardiovascular events therefore no
comparison could be calculated between both age groups.
gEarly vascular dementia; researchers decided that participating partner was allowed to help filling in the questionnaires and diary.
hPearson’s Chi-Square test or Fisher Exact test was used, unless otherwise specified.
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Figure 1. Flowchart of participants in the ELDEST study. 1 Only performed by participating travelers at two of the four clinics. 6CIT, Six Item Cognitive
Impairment Test; IC, Informed Consent; LUMC, Leiden University Medical Centre; MHS, Municipal Health Service; Q, Questionnaire.
Malaria prophylaxis
If malaria prophylaxis was indicated (n = 147), chemoprophy-
laxis and mosquito nets were used in 82% and 80% of travellers,
respectively. Atovaquone/proguanil was mostly used (93%); only
one traveller used mefloquine (1%). Most travellers were fully
compliant (92%). Side effects are listed in Supplementary Table
S4. No cases of malaria were reported.
Morbidity during and shortly after travel
One out of 5 travellers (21%) suffered from a RTI, of which 1 in
10 travellers had a pre-existent pulmonary disease [e.g. asthma
or chronic obstructive pulmonary disease (COPD)]. Almost one
third of the RTIs (27%) were complicated (Table 2). One in
six travellers with an uncomplicated RTI also reported these
complaints pre-travel. Among all 98 travellers with an RTI, 30%
experienced inconvenience, 16% used an antibiotic and 12%
consulted a doctor.
Gastroenteritis (GE) was observed in 47 travellers (10%), of
which 6 (13%) were complicated (Table 2). One in five travellers
had a gastrointestinal disease in their medical history, mostly gas-
troesophageal reflux or irritable bowel syndrome. Almost half
of the travellers (46%) with uncomplicated and all complicated
GE experienced inconvenience and altered their program or
stayed in their accommodation. Eight travellers (20%) consulted
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N = 34 a
4–8 weeks
post-travel







Type of medical assistance b
General practitioner 4 (57) 28 (85)d 27 (79) 14 (61) 69 (87) 73 (87)
Medical specialist 0 2 (6) 6 (18)e 7 (30) 15 (19) 15 (18)
Emergency room 3 (43) 0 0 0 0 3 (4)
Hospital admission 0 3 (9)f 1 (3)g 1 (4)h 5 (6) 5 (6)
Reason for seeking medical assistance
Infections (general) 0 2 (6) 2 (6) 0 4 (5) 4 (5)
Gastrointestinal complaints 3 (43) 6 (18) 4 (12) 5 (22) 15 (19) 18 (21)
Dehydration 0 1 (3) 0 0 1 (1) 1 (1)
Respiratory complaints 0 7 (21) 10 (29) 6 (26) 23 (29) 23 (27)
Urinary tract complaints 0 1 (3) 2 (6) 3 (13) 6 (8) 6 (7)
Cardiovascular complaints 0 1 (3) 3 (9) 0 4 (5) 4 (5)
Peripheral edema 0 3 (9) 0 0 3 (4) 3 (4)
Musculoskeletal complaints 0 3 (9) 6 (18) 3 (13) 12 (15) 12 (14)
Ear nose throat complaints 1 (14) 6 (18) 2 (6) 3 (13) 11 (14) 12 (14)
Other 3 (43) 3 (9) 5 (15) 2 (9) 10 (13) 13 (15)
Total medical consultations c 7 (100) 33 (100) 34 (100) 22 (96) 89 (113) 97 (115)
Data represent absolute numbers (N) and percentages (%). Medical support for complaints that were (possibly) travel-related, as was judged by a clinician.
Regular medical appointments such as annual influenza vaccination of measuring blood pressure were excluded.
aIn the period of 2–4 weeks post-travel, three travellers were lost to follow-up. In the period 4–8 weeks post-travel, an additional three travellers who did reported medical complaints
in questionnaire 3 did not fill in questionnaire 4.
bTravellers that received multiple types of medical assistance were only indicated once in the table at the highest level of care that was received.
cTotals may exceed 100% since some travellers sought medical support multiple times (10 travellers twice, 1 traveller thrice).
dAmong which one traveller with African tick bite fever.
eAmong which one traveller with scabies.
fDehydration due to gastroenteritis, acute cardiac failure and arthritis.
gSepsis.
hAcute cholecystitis.
of contracting GE appeared to be higher for travellers using a
proton-pump inhibitor, but was not significant (RR = 1.75, 95%
CI 0.97 to 3.18, P = 0.07). Dehydration occurred in 18 travellers
(4%), of whom 6 had GE, and 4 were taking diuretics. Two
dehydrated travellers (11%) used ORS.
Despite the presence of comorbidities in 40% of travellers, ex-
acerbations of pre-existent conditions were reported in only 5%
of the travellers (Supplementary Table S5). Eight travellers (2%)
experienced cardiovascular complaints; 88% had a pre-existing
cardiovascular disease such as hypertension or cardiac arrhyth-
mias (Table 2). One traveller with cardiac arrhythmia consulted a
doctor. In 59 travellers (12%) with peripheral edema, 47% had a
medical history of cardiovascular disease (mostly hypertension).
A higher comorbidity burden (CCI) and the use of more daily
medication was associated with a higher travel-related morbidity
(P = 0.04 and P = 0.14 respectively, data not shown).
A total of 61 travellers (13%) suffered mostly minor injuries,
such as cuts, abrasions or spraining (Supplementary Table S5)
often caused by accidental falling (30%). No fractures were
reported. One traveller reported a dog bite (WHO category II)
in Malawi.
Medical assistance
Medical assistance for health complaints possibly related to their
travel was primarily sought between the first week to 2 months
after return (81%), mostly at the GP (87%). Respiratory (27%)
and gastrointestinal complaints (21%) were the main reasons of
consultation. Only seven travellers consulted a GP (57%) or an
emergency room (43%) during travel, mostly for gastrointestinal
complaints, wounds or altitude sickness. Five travellers were
hospitalized post-travel, none during travel. No mortality was
observed (Table 3).
Self-reported health
There was a significant improvement in mental health sum score
and associated domains during travel (all P < 0.001). Improve-
ment in self-perceived physical health was observed within the
bodily pain domain (P < 0.001, data not shown). After travel,
there were still significant improvements noticeable in the men-
tal health sum score, vitality and general mental health (all
P < 0.001) in comparison with pre-travel. In addition, a signifi-
cant improvement in the physical health sum score (P = 0.01) and
bodily pain (P < 0.001) were observed (Supplementary Table S6).
Predictors for travel-related morbidity
Multivariable analysis demonstrated that traveling to Northern
Africa or South-East and East Asia, phone and social media use,
higher CCI score, higher number of medications per day, more
tropical travel experience and longer travel duration seemed to
be associated with increasing odds for travel-related morbidity.
Travellers with a better SF-36 mental health sum score pre-
travel, traveling with family and travellers with higher education
appeared to have reduced odds for travel-related morbidity.
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Table 4. Best predicting characteristics for developing travel-related morbidity in 475 older travellers to the tropics
No morbidity Morbidity Univariable analysis Multivariable analysis
N = 281 N = 194 OR [95% CI] P value OR [95% CI] P value
Gender, female 131 (47) 100 (52) 1.22 [0.84–1.78] 0.29
Age, years, median (IQR) 66 (62–70) 66 (63–71) 1.02 [0.98–1.05] 0.30
Educational level
Primary education (=ref) 19 (7) 19 (10) 1.00 0.04 1.00 0.03
Secondary education 85 (30) 75 (39) 0.88 [0.44–1.79] 0.80 [0.37–1.74]
Higher education 177 (63) 100 (52) 0.57 [0.27–1.12] 0.48 [0.23–1.02]
Immigrant 23 (8) 15 (8%) 0.94 [0.48–1.85] 0.86
Travel advice obtained at MHS 101 (36) 71 (37) 1.03 [0.70–1.50] 0.88
Travel experience to tropics: number of journeys
in preceding 5 years, median (IQR)
2 (1–5) 2 (1–5) 1.00 [0.98–1.02] 0.95 1.05 [0.985–1.13] 0.13
Tropical travel destination
Caribbean, Central and South America (=ref) 44 (16) 36 (19) 1.00 0.03 1.00 0.02
Northern Africa 4 (1) 7 (4) 2.14 [0.58–7.88] 3.8 [0.91–15.82]
Sub Saharan Africa 88 (31) 37 (19) 0.51 [0.29–0.92] 0.63 [0.34–1.20]
Central, South and Western Asia/Middle East 102 (36) 76 (39) 0.91 [0.54–1.55] 0.87 [0.49–1.56]
South-East and East Asia 42 (15) 38 (20) 1.11 [0.59–2.06] 1.56 [0.78–3.11]
Travel duration, days, median (IQR) 18 (14–23) 20 (15–24) 1.03 [1.01–1.06] 0.02 1.04 [1.004–1.070] 0.03
Duration between pre-travel consult and
departure, days, median (IQR)
38 (21–52) 37 (22–50) 1.00 [0.99–1.00] 0.44
Purpose of travel
Business (=ref) 10 (4) 5 (3) 1.00 0.79
Visiting friends or relatives 40 (14) 30 (15) 1.50 [0.46–4.85]
All other 231 (82) 159 (82) 1.38 [0.46–4.10]
Travel group composition
With an organized group travel (=ref) 50 (18) 46 (24) 1.00 0.17 1.00 0.12
With family 191 (68) 116 (60) 0.66 [0.42–1.05] 0.63 [0.38–1.04]
All other 40 (14) 32 (16) 0.87 [0.47–1.61] 0.94 [0.47–1.85]
Type of accommodation during travel
Accommodation owned by
participant/family/friends (=ref)
26 (9) 20 (10) 1.00 0.43
Luxurious rented accomodation 241 (86) 159 (82) 0.86 [0.47–1.60]
Nonluxurious accomodation 13 (5) 15 (8) 1.39 [0.55–3.54]
Phone use
No phone (=ref) 7 (2) 4 (2) 1.00 0.16 1.00 0.11
Regular mobile phone 33 (12) 35 (18) 1.86 [0.50–6.93] 2.24 [0.53–9.44]
Smartphone 241 (86) 155 (80) 1.13 [0.32–3.91] 1.21 [0.31–4.77]
Social media use 166 (59) 119 (61) 1.08 [0.74–1.57] 0.69 1.55 [0.996–2.42] 0.05
BMI, kg/m2, median, (IQR) 25 (23–27) 25 (23–28) 1.02 [0.97–1.07] 0.51
Sensory function
Wearing hearing aid 30 (11) 23 (12) 1.13 [0.63–2.01] 0.67
Wearing glasses or contact lenses 220 (78) 144 (74) 0.82 [0.53–1.25] 0.35
Katz-ADL score, median (IQR) 0 (0–0) 0 (0–0) 1.23 [0.46–3.60] 0.63
6CIT total score, median (IQR)a 0 (0–2) 2 (2–2) 1.13 [1.01–1.27] 0.04
Grip strength, kg, median (IQR) 36 (28–46) 32 (28–44) 0.99 [0.97–1.01] 0.15
Influenza vaccination received < 1 year 147 (53) 116 (60) 1.13 [0.91–1.92] 0.14
Number of daily medications, median (IQR) 1 (0–3) 2 (0–4) 1.13 [1.05–1.22] 0.001 1.07 [0.977–1.17] 0.14
CCI score, median (IQR) 0 (0–1) 0 (0–2) 1.20 [1.06–1.35] 0.003 1.15 [1.006–1.31] 0.04
SF-36 sum scores pre-travel, median (IQR)
Physical health 92 (85–95) 87 (77–93) 0.97 [0.95–0.98] <0.001
Mental health 90 (86–94) 87 (79–91) 0.96 [0.94–0.98] <0.001 0.96 [0.944–0.981] <0.001
Data represent absolute numbers (N) and percentages per category (%), unless otherwise specified. Variables were selected for the multivariable regression analysis using backward
selection until the Akaike information criterion (P ≤ 0.157) was satisfied. Abbreviations: OR, odds ratio; IQR, interquartile range; ref, reference; MHS, Municipal Health Service; BMI,
body mass index; Katz-ADL, Katz activities of daily living; 6CIT, Six Item Cognitive Impairment Test; CCI, Charlson comorbidity index; SF-36, Short-Form 36 survey.
aNot included in the multivariable regression analyses since measurements were unavailable for travellers included at the Municipal Health Services. Model: constant = 9.02, Nagelkerke
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Discussion
In this multicentre prospective study we assessed whether phys-
ical and cognitive performance tests could predict travel-related
morbidity in Dutch older travellers during a short-term stay in
the tropics. We found that a higher CCI score and higher number
of daily medications, but also more tropical experience, longer
travel duration, traveling to Northern Africa or South-East and
East Asia, and phone and social media use were associated
with higher odds for travel-related morbidity. The participants
were generally experienced and well-educated, physically and
mentally fit with little (co)morbidity or polypharmacy and well-
connected to the digital world of internet, social media and
smartphones. As expected, travellers in higher age groups scored
worse on performance measurements although these groups were
not identified as predictors.
Our cohort had considerable travel experience, was well-
prepared for their tropical trip, and showed limited risk-seeking
behaviour. This last aspect is in line with the retrospective study
of Alon et al. who demonstrated that older travellers practiced
less risky eating and drinking habits and were more compliant
with anti-malarial chemoprophylaxis than younger travellers.7
Most older travellers in our cohort were fully compliant (92%).
It is noteworthy that a substantial number of our travellers used a
smartphone and social media. This could imply that these meth-
ods of communication could be used for future (intervention)
strategies as mobile technology will impact travel medicine more
and more.43–45
In accordance with previous literature,6 ,7 older travellers fre-
quently experienced ‘classic’ travel-related morbidities, such as
gastrointestinal and respiratory infections, but they also reported
complaints which are more likely to occur in older people such as
dehydration (4%), cardiovascular complaints (2%), peripheral
edema (12%) and accidental falls (4%). Unexpectedly, exacer-
bations of pre-existing illness were only rarely reported. In the
post-travel questionnaire 141 travellers (30%) reported to have
experienced diarrhoea, of whom 12 travellers did not temporar-
ily stop their diuretics. Since older persons are more prone to
complications such as hypotension or renal failure following
dehydration, it is important to discuss during the pre-travel
consult in which situations diuretics should be discontinued (e.g.
during periods of vomiting and/or diarrhoea).46 Less anticipated
complaints were injuries (13%), skin (12%) and musculoskeletal
complaints (2%). Especially falling deserves further investiga-
tion, as falls are a major determinant of morbidity and mortality
in older adults.47 ,48
Medical assistance was frequently sought, but mostly post-
travel. Underlying reasons for late medical consultation were
not studied. Possible explanations are previous experience with
similar complaints that appear to be self-limiting, preference
for own GP, or unexpected longer duration of complaints after
travel.49
Our findings that older travellers experienced significant
improvement in the self-reported mental- and physical health
during and after travel extend earlier findings.50–52 This kind of
effects of travel appears to have a positive effect on the perceived
health of the traveller and could therefore outweigh the impact
of health problems. Although this positive effect decreased on
return, travellers still experienced improved health as compared
with before travel.50 A survey study on the well-being and
health among employees of German companies after a, mostly
European, holiday revealed that enough leisure time, warmer
destinations, being physically active, good sleep and making new
social contacts facilitate improved health whereas dealing with
a greater time-zone difference (i.e. jetlag) was associated with
a decreased health.52 Most of our study participants travelled
to warmer tropical destinations, whereby they frequently cross
different time-zones. Interestingly, in the employee study an older
subgroup aged 50–62 (18%) was analysed, and they found that
age was associated with differences in holiday organization (e.g.
duration and travel time), but did not affect the positive health
changes on its own.52 The findings in our study cohort underline
that traveling to the tropics does not only entail morbidity for
the older traveller, but could positively affect both their mental
and physical health. We did not address possible improvements
on existing co-morbidities.
We hypothesized that pre-travel, validated physical and men-
tal health performance measures might identify older travellers
more at risk for travel-related morbidity. Grip strength was
chosen as an objective measure of physical performance, but
no association was found. The same holds for the level of
independence measured with Katz-ADL. A possible explanation
for these findings could be that most included travellers are fit
and living an active and independent life, what enables them to
undertake tropical journeys.
Finally, we identified several demographic (phone and social
media use), travel (duration, destination, experience) and health
characteristics (CCI and medication) as predictors of travel-
related morbidity. We used the Akaike information criterion in
order not to overlook any important associations. In line with
our findings, previous research also identified travel duration and
destination as predictors, but not specifically in the older trav-
eller.50 ,53 Interestingly, age was not found to be an independent
predictor for morbidity, even though pre-travel characteristics
were found to be significantly different when comparing age
groups (Table 1). The direction of some effect sizes seems coun-
terintuitive (e.g. more travel experience seems to be associated
with higher morbidity rates). It is therefore important to note that
this model aimed to identify prognostic and not etiologic rela-
tionships between characteristics and travel-related morbidity.
This relationship might be confounded by other characteristics,
such as risk behaviour.12 ,53 Risk behaviour was not included in
the multivariable regression model, since this cannot validly be
measured pre-travel.54 The identified predictors could be used
to identify older travellers with a relatively high risk for travel-
related morbidity. Most of them could be easily assessed since
they are part of the current pre-travel consultation (destination,
duration and travel experience) or could easily be assessed at
that moment (educational level, phone and social media use and
CCI score). Future research should be conducted to confirm the
association between the identified predictors and travel-related
morbidity.
The strengths of this study are the multicentre approach, the
large sample size of >100 travellers aged 70 and over, the high
follow-up rate of 97%, the limitation of recall bias using a diary
during travel and questionnaire shortly after return, the use of
validated measurement tools, the use of well-defined symptom
clusters to quantify reported morbidity and the collection of
baseline data before departure which limits selection bias and
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The study also has some limitations that need to be discussed.
This study population might not be completely representative
for the older population in general (‘healthy traveller bias’).
Compared with travellers who participated only in part A or
partly in B, travellers who participated in A and B were slightly
younger, had a higher grip strength and were less cognitively
impaired (Supplementary Table S7). Also, when other aspects
are taken into account, our travellers appeared to be fitter than
the average age-matched Dutch population. A pre-existing illness
was reported by 40% of our travellers, which is lower than the
anticipated 50% in the general non-travelling Dutch population
of 65 years and older,55 but comparable with the 43% in Swiss
travellers who also visited non-tropical destionations.56 Also
polypharmacy was somewhat lower in our study population
(16%) than the 20% rate in the Dutch population aged 55 years
and older.57 Therefore, the true incidence of morbidity in the
older traveller might be higher. For that reason, we also compared
the data of our group travellers aged between 70 and 79 years
(n = 117) with the data from individuals of the same age group of
the AT-AGE study (n = 303) in which an identical measurement
procedure had been used in different primary care practices.58
Linear regression demonstrated no significant mean difference in
the maximal grip strength between both cohorts, after correcting
for age and gender (mean difference 1.3, 95% CI −0.2 to 2.8,
P = 0.096). This implied that the older travellers visiting the clinic
pre-travel physically did not differ (much) from the older adults
visiting primary care practices. Of interest, a recent retrospective
study among older travellers visiting an Irish travel health clinic
pre-travel demonstrated similar health (e.g. about one third used
no medication, majority had a medical condition) and travel
characteristics (e.g. South Eastern Asia and South America as
popular destinations, travel duration of 3 weeks, mostly traveling
for leisure or visiting friends or family) as in this ELDEST
cohort.59
In practice
This study demonstrates that older Dutch travellers to the trop-
ics are generally fit, well-prepared and experienced relatively
low rates of morbidity. Although several travellers encountered
travel-related morbidity, these travellers did not solely entail
illness, as the participants perceived both improved mental- and
physical health after travel. Special attention should be given to
travellers with the identified predictors (e.g. long travel duration,
destinations in Northern Africa or South-East and East Asia, high
CCI score, multiple daily medications, using a mobile phone and
media use). Furthermore, extensive travel experience should not
reassure the travel advisor.
Supplementary data
Supplementary data are available at Journal of Travel Medicine
online.
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